Biofunctional properties of bioactive peptides of milk origin

Food Reviews International

Volumn 25, Issue 1, 2009, Pages 28-43

  Haque, E ^a   Chand, R ^a   Kapila, S ^a  

^a NATIONAL DAIRY RESEARCH INSTITUTE   (India)

Author keywords

Bioactive peptide; Dairy products; Milk protein; Proteolysis

Indexed keywords

BIOACTIVE PEPTIDES; BIOLOGICALLY ACTIVE SUBSTANCES; FUNCTIONAL FOODS; HEALTH BENEFITS; IMMUNOMODULATORY; MILK PROTEIN; NATIVE PROTEINS; PHYSIOLOGICAL ACTIVITY;

DAIRY PRODUCTS; ENZYMATIC HYDROLYSIS; PROTEOLYSIS;

PEPTIDES;

EID: 58149132303     PISSN: 87559129     EISSN: 15256103     Source Type: Journal    
DOI: 10.1080/87559120802458198     Document Type: Article

References (100)

1. Meisel, H. Biochemical properties of regulatory peptides derived from milk proteins. Biopolymers 1997, 43, 119-128.
2. Korhonen, H.; Pihlanto A. Bioactive peptides: New challenges and opportunities for the dairy industry. Aus. J. Dairy Technol. 2003, 58, 129-134.
3. Meisel, H. Overview on milk protein-derived peptides. Int. Dairy J. 1998, 8, 363-373.
4. Korhonen, H.; Pihlanto A., Bioactive peptides: Novel applications for milk proteins. Appl. Biotechnol. Food Sci. Policy 2003, 1, 133-144.
5. Korhonen, H.; Pihlanto, A. Food-derived bioactive peptides-opportunities for designing future foods. Curr. Pharm. Design 2003, 9, 1297-1308.
6. Korhonen, H.; Pihlanto Leppala -A. Bioactive peptides: Production and functionality. Int. Dairy J. 2006, 16, 945-960.
7. Fiat, AM; Migliore-Samour, D.; Jolles, P.; Drouet, I.; Bal Dit Soitier, C; Caen, J. Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities. J. Dairy Sci. 1993, 76, 301-310.
8. Severin, S.; Wenshui, X. Milk biologically active components as nutraeeuticals: review. Crit. Rev. Food Sci. Nutr. 2005, 45, 645-656.
9. Narva, M., Effects of Lactobacillus helveticus fermented milk-derived bioactive peptides (CPP, IPP, and VPP) on calcium and bone metabolism, Doctoral thesis, University of Helsinky, Helsinky, 2004.
10. Gobbetti, M.; Stepaniak, L.; De Angelis, M.; Corsetti, A.; Di Cagno, R. Latent bioactive peptides in milk proteins: Proteolytic activation and significance in dairy processing. Crit. Rev. Food Sci. Nutr. 2002, 42, 223-239.
11. Korhonen, H.; Pihlanto-Leppälä, A. Milk protein-derived bioactive peptides-novel opportunities for health promotion. IDF Bulletin 2001, 363, 17-26.
12. Korhonen, H.; Pihlanto-Leppälä, A. (2004) Milk-derived bioactive peptides: Formation and prospects for health promotion. In Handbook of Functional Dairy Products. Functional Foods and Nutraceuticals Series 6.0; CRC Press: FL, 109-124.
13. Matar, C. Valdez, J.C.; Medina, M.; Rachid, M.; Perdigon G. Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J. Dairy Res. 2001, 68, 601-609.
14. Meisel, H.; Bockelmann, W. Bioactive peptides encrypted in milk proteins: Proteolytic activation and thropho-functional properties. Antonie van Leeuwenhoek 1999, 76, 207-215.
15. Roudot-Algaron, F.; LeBars, D.; Kerhoas, L.; Einhom, J; Gripon, J.C. Phosphopeptides from Comte cheese: Nature and origin. J. Food Sci. 1994, 59, 544-547.
16. Singh, T.K.; Fox, P.F; Healy, A. Isolation and identification of further peptides in the diafiltration retentate of the water-soluble fraction of Cheddar cheese. J. Dairy Res. 1997, 64, 433-443.
17. Meisel, H.; Goepfert, A.; Günther, S.; ACE-inhibitory activities in milk products. Milchwissenschaft 1997, 52, 307-311.
18. Ryhänen, E.L.; Pihlanto-Leppälä A.; Pahkala E. A new type of ripened; low-fat cheese with bioactive properties. Int. Dairy J. 2001, 11, 441-447.
19. Saito, T.; Nakamura, T.; Kitazawa, H.; Kawai, Y.; Itoh, T. Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. J. Dairy Sci. 2000, 83, 1434-1440.
20. Gomez-Ruiz, J.A.; Ramos, M.; Recio, I. Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures. Int. Dairy J. 2002, 12, 697-706.
21. Gagnaire, V.; Molle, D.; Herrouin, M.; Leonil, J. Peptides identified during Emmental cheese ripening: Origin and proteolytic systems involved. J. Agric. Food, Chem. 2001, 49, 4402-4413.
22. Smacchi, E.; Gobbetti, M. Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria; Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme. Enz. Microbiol. Technol. 1998, 22, 687-694.
23. Hernández-Ledesma, B.; Amigo, L.; Ramos, M.; Recio, I. Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion, J. Agric. Food Chem. 2004, 52, 1504-1510.
24. Lund M., Ardö Y. Purification and Identification of Water-Soluble Phosphopeptides from Cheese Using Fe(III) Affinity Chromatography and Mass Spectrometry J. Agric. Food Chem. 2004, 52, 6616-6622.
25. Rokka, T.; Syväoja, E-L.; Tuominen, J.; Korhonen, H. Release of bioactive peptides by enzymatic proteolysis of Lactobacillus GG fermented UHT-milk. Milchwissenschaft 1997, 52, 675-678.
26. Gobbetti, M.; Minervini, F.; Rizzello, C.G.; Angiotensin I-converting-enzyme-inhibitory and antimicrobial bioactive peptides. Int. J. Dairy Technol. 2004, 57, 172-188.
27. Fitz Gerald, R.J.; Murray, B.A.; Walsh, D.J. Hypotensive peptides from milk proteins. J. Nutr. 2004, 134, 980S-988S.
28. Yamamoto, N.; Maeno, M.; Takano, T.; Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. J. Dairy Sci. 1999, 82, 1388-1393.
29. Nakamura, Y.; Yamamoto, M.; Sakai, K.; Okubo, A.; Yamazaki, S.; Takano, T. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J. Dairy Sci. 1995, 78, 777-783.
30. Ashar, M.N.; Chand, R. Fermented milk containing ACE-inhibitory peptides reduces blood pressure in middle aged hypertensive subjects. Milchwissenschaft 2004 59, 363-366.
31. Haileselassie, SS.; Lee, BH.; Gibbs, BF. J. Purification and Identification of Potentially Bioactive Peptides from Enzyme-Modified Cheese J. Dairy Sci. 1999, 82, 1612.
32. Teschemacher, H.; Koch, G.; Brantl, V. Milk protein-derived opioid receptor ligands. Biopolymers 1997, 43, 99-117.
33. Paroli E. Opioid peptides from food (the exorphins) World Rev. Nutr. Diet 1988, 55, 58-97.
34. Brantl, V.; Teschemacher, H.; Henschen, A.; Lottspeich, F. Novel opioid peptides derived from casein (β casomorphins) Isolation from bovine casein peptone. Hoppe Seyler's Z. Physiol. Chem. 1979, 360, 1211-1216.
35. Teschemacher, H.; Brantl, V. Milk protein derived atypical opioid peptides and related compounds with opioid antagonist activity. In β-Casomorphins and Related Peptides: Recent Developments; Brantl, V.; Teschemacher, H. Eds.; VCH: Weinheim, 1994; 3-17.
36. Chiba, H.; Yoshikawa M. Biologically functional peptides from food proteins: New opioid peptides from milk proteins. In Protein Tailoring for Food and Medical Uses; Feeney, R.E.; Whitaker, J.R. Eds.; Marcel Dekkerlnc: New York, 1986; 123-153.
37. Pihlanto-Leppälä A. Bioactive peptides derived from bovine whey proteins: Opioid and ACE-inhibitory peptides. Trend. Food Sci. Technol. 2001, 11, 347-356.
38. Antila, P.; Paakkari, I.; Jarvinen, A.; Mattila, M.J.; Laukkanen, M.; Pihlanto-Leppälä A.; Mantsala, P.; Hellman. J. Opioid peptides derived from in vitro proteolysis of bovine whey proteins. Int. Dairy J. 1991, 1 215-229.
39. Sipola, M.; Finckenberg, P.; Vapaatalo, H.; Pihlanto-Leppala, A.; Korhonen, H; Korpela, R. α-Lactorphin and β-lactorphin improve arterial function in spontaneously hypertensive rats. Life Sci. 2002, 71, 1245-1253.
40. Chiba, H.; Tani, F.; Yoshikawa, M. Opioid antagonist peptides derived from K-casein. J. Dairy Res. 1989, 56, 363-366.
41. sl-casein. In β-Casomorphins and Related Peptides: Recent Developments; Brantl, V.; Teschemacher, H.; Eds.; VCH: Weinheim, 1994; 43-48.
42. Yoshikawa. M; Tani, F.: Chiba, H. Structure-activity relationship of opioid antagonist peptides derived from milk proteins. In Peptide Chemistry Protein Research Foundation; Shiba, T.; Ed.; Osaka, 1988: 473-476.
43. Daniel, H.; Vohwinkel, M.; Rehner, G. Effect of casein and β-casomorphin on gastrointestinal motility in rats. J. Nutr. 1990, 120, 252-257.
44. Tomé, D.; Dumontier, AM.; Hautefeuille, M.: Desjeux, JF. Opiate activity and transepithelial passage of intact β-casomorphins in rabbit ileum. Am. J. Physiol. 1987, 253, G737-G744.
45. Brandsch, M.; Brust, P.; Neubert, K.; Ermisch, A. (1994). P-Casomorphins - chemical signals of intestinal transport systems. In: Brantl V & Teschemacher H (Eds) β-Casomorphins and Related Peptides: Recent Developments VCH, Weinheim, 207-219.
46. Meisel, H.; FitzGerald, R.J. Opioid peptides encrypted in intact milk protein sequences, Br. J. Nutr. 2000, 84, 27-31.
47. Fitz Gerald, R. J.; Meisel, H. Milk protein hydrolysates and bioactive peptides. In Advanced dairy chemistry, Vol. 1, Proteins, 3rd ed.: Fox, P.F.; McSweeney, P.L.H.; Eds.: New York, 2003; 675-698.
48. Umbach M. Teschemacher H. Praetorius K. Hirschhäuser R & Bostedt H (1985) Demonstration of a β-casomorphin immunoreactive material in the plasma of newborn calves after milk intake. Regulatory Peptides 1985, 12, 223-230.
49. Sturner, R.A.; Chang, K.J. Opioid peptide content in infant formulas. Pediatric Res. 1988, 23, 4-10.
50. Meisel, H. Casokinins as inhibitors of angiotensin I converting enzyme. In New perspectives in infant nutrition; Sawatzki, G.; Renner, B.; Eds.; Thieme: Stuttgart, New York, 1993; 153-159.
51. Fitz Gerald, R.J.; Meisel, H. Milk protein derived inhibitors of angiotensin-I-converting enzyme, Br. J. Nutr. 2000, 84, S33-S37.
52. Nakamura, Y.; Yamamoto, N.: Sakai, K.; Takano, T. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme, J. Dairy Sci. 1995, 78, 1253-1257.
53. Yamamoto, N.; Akino, A.; Takano, T. Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 1994, 77, 917-922.
54. Maeno, M.: Yamamoto, N.; Takano, T. Isolation of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790, J. Dairy Sci. 1996, 79, 1316-1321.
55. Murakami, M.; Tonouchi, H.; Takahashi, R.; Kitazawa, H.; Kawai, Y.; Negishi, H. et al. Structural analysis of a new anti-hypertensive peptide (β-lactosin B) isolated from a commercial whey product, J. Dairy Sci. 2004, 87, 1967-1974.
56. Sekiya, S.; Kobayashi, Y.; Kita, E.; Imamura, Y.; Toyama, S. Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers. J. Jap. Soc. Nutr. Food Sci. 1992, 45, 513-517.
57. Hata, Y.; Yamamoto, M.; Ohni, H.; Nakajima, K.; Nakamura, Y.; Takano, T. A placebocontrolled study of the effect of sour milk on blood pressure in hypertensive subjects. Am. J. Clin. Nutr. 1996, 64, 767-771.
58. Yamamoto, N.; Ejiri, M.; Mizuno, S. Biogenic peptides and their potential use. Curr. Pharm. Design 2003, 9, 1345-1355.
59. Mizushima, S.; Ohshige, K.; Watanabe, J.; Kimura, M.; Kadowaki, T.; Nakamura, Y. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am. J. Hyperten 2004, 17, 701-706.
60. Mizuno, S.; Nishimura, S.; Matsuura, K.; Gotou, T.; Yamamoto, N. Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease, J. Dairy Sci. 2004, 87, 3183-3188.
61. Seppo, L.; Jauhiainen, T.; Poussa, T.; Korpela, R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr 2003, 77, 326-330.
62. Seppo, L.; Kerojoki, O.; Suomalainen, T.; Korpela, R. The effect of a Lactobacillus helveticus LBK-16H fermented milk on hypertension - a pilot study on humans Milchwissenschaft 2002, 57, 124-127.
63. Maruyama, S.; Mitachi, H.; Tanaka, H.; Tomizuka, N.; Suzuki, H. Studies on the active site and antihypertensive activity of angiotensin I-converting enzyme inhibitors derived from casein. Agric. Biol. Chem. 1987, 51, 1581-1586.
64. Masuda, O.; Nakamura, Y.; Takano, T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J. Nutr. 1996, 126, 3063-3068.
65. Kim, Y.S.; Bertwhistle, W.; Kim, Y.W. Peptide hydrolyses in the brush border and soluble fractions of small intestinal mucosa of rat and man. J. Clin. Invest. 1972, 51, 1419-1430.
66. Adibi, S.A.; Kim, Y.S. 1981. In Physiology of Gastrointestinal Tract; (Johnson, L.R.; Ed.); Raven Press: New York; 1097-1122.
67. Mock, W.L.; Green, P.C.; Boyer, K.D. Specificity and pH dependence for acylproline cleavage by prolidase. J. Biol. Chem. 1990, 265, 19, 600-19, 605.
68. Mullally, M.M.; Meisel, H.; Fitz Gerald, R.J. Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine β-lactoglobulin. FEBS Lett. 1997, 402, 99-101.
69. Vermeirssen, V.; van Camp, J.; Verstraete, W. Bioavailability of angiotensin I-converting enzyme inhibitory peptides. Br. J. Nutr. 2004, 92, 357-366.
70. Perez-Castrillon, J.L.; Justo, L; Silva, J.; Sanz, A.; Martin-Escudero, J.C.; Igea R., Escudero, P.; Pueyo, C; Diaz, C. Hernandez G., Duenas A. Relationship between bone mineral density and angiotensin converting enzyme polymorphism in hypertensive postmenopausal women. Am. J. Hyperten. 2003, 16, 233-235.
71. Haiwara, H.; Hiruma, Y.; Inoue, A.; Yamaguchi, A.; Hirose, S. Deceleration by angiotensin II of differentiation and bone foemation of rat calvarial osteoblastic cells. J. Endocrinol 1998, 156, 543-550.
72. Hatton, R.; Stimpel, M.; Chambers, T.J. Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J. Endocrinol 1997, 152, 5-10.
73. Higgins, R.D.; Yan, Y.; Geng, Y.; Shara, J.; Barr, S.M. Captopril and vascular endothelial growth factor in a mouse model of retinopathy. Curr. Eye. Res. 2003, 27, 123-129.
74. Van't Hof, R.J.; Ralston, S.H. Nitric oxide and bone. Immunology 2001, 103, 255-261.
75. Clare, D.A.; Swaisgood, H.E. Bioactive milk peptides: A prospectus, J. Dairy Sci. 2000, 83, 1187-1195.
76. Migliore-Samour, D.; Floc'h, F.; Jollés, P. Biologically active casein peptides implicated in immunomodulation, J. Dairy Res. 1989, 56, 357-362.
77. Coste, M.; Rochet, V.; Leonil, J.; Molle, D.; Bouhallab, S.; Tome, D. Identification of C-temninal peptides from bovine |3-casein that enhance proliferation on rat lymohocytes. Immunology Lett. 1992, 33, 41-46.
78. Elitsur. Y.; Luke, G.D. Beta-casomorphin (BCM) and human colonic lamina propria lymphocyte proliferation. Clin. Experiment. Immunol. 1991, 85, 493-497.
79. Matar, C; LeBlanc, J.G.; Martin, L.; Perdigon, G. (2003) Biologically active peptides released in fermented milk: Role and functions. In Hmulbook of fermented functional foods. Functional foods and nutraceuticals series; Farnworth, E.D.; Ed.; CRC Press: Boca Raton, FL, 2003; 177-201.
80. sl-casein digest as a factor influencing proliferation and immunoglobulin production in lymphocyte cultures. J. Dairy Res. 1998, 65, 569-578.
81. Pagelow, I.; Werner, H. Immunomodulation by some oligopeptides. Method. Findings Exp. Clin. Pharm. 1986, 8, 91-95.
82. Hata, I.; Ueda, J.; Otani, H. Immunostimulatory action of a commercially available casein phosphopeptides preparation, CPP-III, in cell cultures, Milchwissenschaft 1999, 54, 3-7.
83. Bernard, H.; Meisel, H.; Creminon, C; Wai, J.M. Post-translational phosphorylation affects the IgE binding capacity of caseins. FEBS Lett. 2000, 467, 239-244.
84. Calder PC. Glutamine and the immune system. Clin. Nutr. 1994, 13, 2-8.
85. Gill, H. Dairy products and the immune function in the elderly. In functional dairy products; Mattila-Sandholm, T.; Saarela, M.; Eds.; CRC: Washington, DC, 2003; 133-167.
86. Bellamy, W.; Takase, M.; Wakabayashi, H.; Kawase, K.; Tomita, M. Antibacterial spectrum of lactoferrin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 1992, 73, 472-479.
87. Vogel H. J.; Schibli D.J.; Weiguo J.; Lohmeier-Vogel E.M.; Epand R.F.; Epand R.M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan and arginine containing peptides. Biochem. Cell Biol. 2002, 80, 49-63.
88. Exposito I. L.; Recio I. Antibacterial activity of peptides and folding variants from milk proteins Int. Dairy J. 2006, 16, 1294-1305.
89. Lahov, E.; Regelson, W. Antibacterial and immunostimulating casein-derived substances from milk: casecidin, isracidin peptides. Food Chem. Toxicol. 1996, 34, 131-145.
90. Recio, I.; Visser S. Two ion-exchange methods for the isolation of antibacterial peptides from lactoferrin-in situ enzymatic hydrolysis on an ion-exchange membrane, J. Chroma tog raphy 1999, 831, 191-201.
91. Schanbacher, F.L.; Talhouk, R.S.; Murray, F.A. Biology and origin of bioactive peptides in milk. Liv. Prod. Sci. 1997, 50, 105-123.
92. Jollés, P.; Henschen, A. Comparison between the clotting of blood and milk. Trend. Biochemical Sci. 1982, 7, 325-328.
93. Jollés, P.; Caen, J.P. Parallels between milk clotting and blood clotting: opportunities for milkderived products. Trend. Food Sci. Technol. 1991, 2, 42-43.
94. Jollés, P.; Lévy-Toledano, S.; Fiat, A.M.; Soria, C; Gillessen, D.; Thomaidis, A.; Dunn, F.W.; Caen, J.B. Analogy between fibrinogen and casein. Eur. J. Biochem. 1986, 158, 379-384.
95. Chabance. B.; Jollés, P.; Izquierdo, C; Mazoyer, E.; Francoual, C; Drouet, L.; Fiat, A.M. Characterization of an antithrombotic peptide from K-casein in new born plasma after milk ingestion. Br. J. Nutr. 1995, 73, 583-590.
96. Rival, S.G.; Fornaroli, S.: Boeriu, C.G.; Wichers, H.J. Caseins and casein hydrolysates. 1. Lipoxygenase inhibitory properties. J. Agric. Food Chem. 2001, 49, 287-294.
97. Kullisaar, T.; Songisepp, E.: Mikelsaar, M.: Zilmer, K.; Vihalemm, T., Zilmer, M. Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects. Br. J. Nutr. 2003, 90, 449-456.
98. Fitz Gerald, R.J. Potential uses of casenophopsphopeptides. Int. Dairy J. 1998, 8, 451-457.
99. Rose, R.K. Binding characteristics of Streptococcus mutans for calcium and casein phosphopeptides. Caries Res. 2000, 345, 427-431.
100. Reynolds, E. Phosphopeptides. 1987. PCT International Patent Application WO87/07615 A1.